Navigation Links
Rapid-response Technology from NeuroInterventions, Inc. Aims to Quickly Restore Brain's Blood Flow After a Stroke
Date:9/13/2009

PITTSBURGH, Sept. 14 /PRNewswire/ -- Driven by the emergency-room maxim, "Time is brain," NeuroInterventions, Inc. is prototyping an innovative stroke treatment device designed to speed up the restoration of blood flow and thus minimize brain damage.

Michele Migliuolo, NeuroInterventions President and COO, will describe the development and his company's background in a presentation at the 3 Rivers Venture Fair in Pittsburgh on Sept. 16.

"In stroke treatment, every lost second means decreased brain function," he says. When a blood clot plugs an artery, blocking the flow of oxygen-rich blood to part of the brain, "the 'window' during which surgery can help is just a matter of hours."

"But, even after a patient reaches a hospital, it can take as long as 60 minutes just to introduce a conventional catheter through the femoral artery and steer it to the site, before you can start to deal with the clot."

NeuroInterventions systems can dissolve or extract clots and, if necessary, deliver medication. Among the key innovations are a shorter, faster path to the brain, and exceptional maneuverability for negotiating the circulatory system's complexities. "Our devices will benefit patients, physicians, hospitals and insurance companies by improving outcomes through shorter, more effective treatment; by permitting more complex procedures; and by reducing recovery times," Dr. Migliuolo says.

Founded in 2007 and based in Pittsburgh, NeuroInterventions is prototyping a family of patent-pending catheters for addressing conditions that include deep vein thrombosis, carotid stenting, traumatic brain injury, and stroke. The technology also facilitates localized drug and stem cell delivery.

The management team includes world leaders in interventional radiology, neurology and neurosurgery, as well as successful entrepreneurs, among them: Lawrence Wechsler, M.D., chair of the Department of Neurology and director of the Stroke Institute at the University of Pittsburgh Medical Center; Mark H. Wholey, M.D., founder and director of the Pittsburgh Vascular Institute; Tudor Jovin, M.D., co-director of the Center for Neuroendovascular Therapy at the University of Pittsburgh Medical Center; Ender Finol, Ph.D., associate research professor for the Institute for Complex Engineered Systems and Biomedical Engineering Department at Carnegie Mellon University; and Dr. Migliuolo, a high-tech entrepreneur and former executive in residence at the Pittsburgh Life Sciences Greenhouse.

    Media contact: Michele Migliuolo, Ph.D.
    info@neurointerventions.com
    412-663-0109


'/>"/>
SOURCE NeuroInterventions, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Winner Medicals Shenzhen Subsidiary Obtained High and New Technology Enterprise Certificate
2. RZN Nutraceuticals Receives United States Patent & Trademark Office Notice of Allowance for Proprietary HerbaZorb(TM) Absorption and Delivery System Technology Used in Popular Arthri-Zen Relief(R) and Migra-Zen Relief PLUS(R) Products
3. BlueSky Synergy, a Division of Amistaff Healthcare Technology, and People 2.0 Global Partner to Provide Complimentary Staffing Software to Participating Companies
4. LifeNet Health and Childrens Mercy Hospital Announce First Implant With MatrACELL(TM) Technology
5. Isis Receives Notice of Allowance That Expands the Scope of Key RNA Therapeutic Patents for Single-Stranded RNAi Technology
6. Stereotaxis Awarded Exclusive Contract by Novation for Robotic Interventional Technology
7. Kapstone Medical Acquires Exclusive License to New Orthopedic Technology
8. Technologies That Redefine Care for Older Americans to be Focus of Conference Session Led by Center for Technology and Aging
9. Methodist Health System Selects Webmedx for Medical Transcription Technology and Services
10. Providers of Packaging Design, Security Printing, and Track and Trace Technology Allign to Provide Multi-Layered Brand Protection Solution
11. Koshland Science Museum explores emerging technology in fall programs
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2016)... ... 24, 2016 , ... A recent article published June 14 on ... article goes on to state that individuals are now more comfortable seeking to undergo ... such as calf and cheek reduction. The Los Angeles area medical group, Beverly Hills ...
(Date:6/24/2016)... ... 24, 2016 , ... Marcy was in a crisis. Her son James, eight, was out of ... verbally and physically. , “When something upset him, he couldn’t control his emotions,” remembers Marcy. ... throw rocks at my other children and say he was going to kill them. ...
(Date:6/24/2016)... CA (PRWEB) , ... June 24, 2016 , ... ... is now offering micro-osteoperforation for accelerated orthodontic treatment. Dr. Cheng has extensive experience ... Damon brackets , AcceleDent, and accelerated osteogenic orthodontics. , Micro-osteoperforation is ...
(Date:6/24/2016)... ... June 24, 2016 , ... People across the U.S. are sharpening ... Talker Award, an essay contest in which patients and their families pay tribute to ... at the 2016 National Society of Genetic Counselors (NSGC) Annual Education Conference (AEC) this ...
(Date:6/24/2016)... Nevada (PRWEB) , ... June 24, 2016 , ... ... Vegas client, The Grove Investment Group (TGIG), has initiated cultivation and processing operations ... in Las Vegas and Pahrump, Nevada. , Puradigm is the manufacturer of a ...
Breaking Medicine News(10 mins):
(Date:6/26/2016)... DUBLIN , June 27, 2016 Jazz ... the waiting period under the Hart-Scott-Rodino Antitrust Improvements Act ... proposed acquisition of Celator Pharmaceuticals, Inc. ("Celator"; Nasdaq: ... 11:59 p.m. (Eastern Daylight Time). As previously ... entered into a definitive merger agreement under which Jazz ...
(Date:6/24/2016)... HILL, N.C. , June 24, 2016 /PRNewswire/ ... healthcare decisions and regulators/payers have placed more emphasis ... new environment, patient support programs in the pharmaceutical ... for patients, medications. Consequently, pharmaceutical companies are focusing ... ensure they are providing products and services that ...
(Date:6/24/2016)... , June 24, 2016   Bay Area ... Network,s Dean Center for Tick Borne Illness ... and Rehabilitation, MIT Hacking Medicine, University of California, ... today announced the five finalists of Lyme ... disease.  More than 100 scientists, clinicians, researchers, entrepreneurs, ...
Breaking Medicine Technology: